Please Wait.....
Report
Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
Market Report I 2022-06-13 I 229 Pages I The Insight Partners
The global branded generics market is projected to reach US$ 414.99 billion by 2028 from US$ 235.86 billion in 2022; it is expected to grow at a CAGR of 9.9% from 2022 to 2028.
Rising penetration of branded generics and increasing government initiatives for promoting branded generics drive the growth of branded generics market. Encouraging utility of branded generics by healthcare providers and professionals acts as a future trend in the branded generics market.
The Association for Accessible Medicines report states that nearly 3.9 billion generic prescriptions were dispensed in 2016. Therefore, branded generics present a viable opportunity for potential growth for big pharma players. According to the published report by HSRII, the US is the largest pharmaceutical market in the world (US$ 325 billion), accounting for one-third of the global pharmaceutical market, with generics accounting for 84% in terms of sales volume and 28% in terms of sales value. Furthermore, branded generics utilization has increased among the population due to savings provided by the healthcare system and the ability to invest in tomorrow's new medicines. For instance, nearly 3.9 billion prescriptions dispensed in the US are for generics. Moreover, on average, in 2016, the use of generic medicines saved each state US$ 4.9 billion compared to the price of relevant branded medicines. This further means that Medicaid savings averaged US$ 744 million, and state Medicaid savings averaged US$ 1.5 billion per state. Such factors accelerate the demand for branded generics, fueling the overall market growth during the forecast period.
Additionally, the rise in government initiatives for promoting branded generics further is accelerating the adoption of branded generics, ultimately stimulating the overall market growth. A Scientific Electronic Library Online (SciELO) report states that promoting branded generics constitutes a core instrument for countries' national pharmaceutical policies, ultimately reducing drug expenditure with expanding healthcare access. For example, to make quality generic medicines available at affordable prices, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in November 2008. The scheme focused on dedicated outlets known as Janaushadhi Kendras, offering generic medicines at affordable prices. Till 2021, 8,012 Janaushadhi Kendras were functional across the country. Moreover, a Food and Drug Administration (FDA) report states that as the FDA approves more branded generics, it results in a drop in cost. Generally, multiple generic drugs for the same product create marketplace competition. For example, a single generic competitor results in price reductions of up to 30%, while five competing generics are associated with a price drop of nearly 85%.
The global branded generics market is segmented based on therapeutic application, distribution channel, drug class, and formulation type. Based on therapeutic application, the branded generics market is segregated into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and others. The others segment is estimated to account for the largest market share during 2022-2028. However, the oncology segment is likely to register the highest CAGR during the forecast period. Generic drugs are also widely used in supportive care during the chemotherapy treatment for oncology. According to the Indian Council for Medical Research (ICMR), in India, the number of Indians who have cancer is projected to increase from 26.7 billion in 2022 to 29.8 billion by 2025. As per the Pharma Intelligence Center, there are currently 1,351 generic drugs available in India for the treatment of various cancers as of February 26, 2021. Most drugs are for the treatment of hematological malignancies, such as blood cancer (606) and leukemia (428). As the cost of branded drugs is higher than generic drugs, maximum people cannot afford these branded drugs and consume generic drugs. Treatment of cancer is limited by the affordability of patients in many developing countries, including India. Therefore, generic drug manufacturers are manufacturing drugs available at affordable costs, often at less than 10% of the original brand cost. It is observed that there is a three-fold higher prescription of generic brands compared to innovators, accompanied by cost savings of up to 80% per prescription. However, the regulatory environment prevailing in India is favorable to ensure satisfactory generic products. These factors are responsible for the growth of this segment, which, eventually, is expected to aid the growth of branded generics market during the forecast period. The others segment is categorized into infectious diseases, musculoskeletal diseases, respiratory diseases, and oral health. According to the Centers for Disease Control and Prevention, in 2018, ~100,000 people in the US suffered from various infectious diseases. Thus, the prevalence of infectious diseases and respiratory diseases, which are treated using generics, is mainly driving the others segment, contributing a considerable share in the branded generics market during the forecast period.
Market Opportunities of Global Branded Generics Market
The opportunity for global branded generics market is product differentiation. The pharmaceutical industry is one of the most intensively regulated sectors, and as a result of these challenges, returns on R&D investment in the pharmaceutical industry have decreased. One feasible alternative for addressing such challenges is adopting strategies such as product differentiation to reduce development costs and maximize profits. Product differentiation deals with developing innovative products based on an existing product by creating better features, performance, or efficacy. Product differentiation paves the way for strengthening product pipeline and lifecycle management. As generic drugs contain the same active pharmaceutical ingredients as the brand-name product, differentiation in the color, shape, taste, inactive ingredients, preservatives, and packaging result in high demand for branded generics globally. Therefore, differentiation in the final product is expected to offer lucrative growth opportunities for the competitive players in the branded generics market.
Additionally, prominent players in the market are focusing on offering low-cost branded generics to remain competitive in the market. This can be achieved by strategically sourcing raw materials from emerging economies and partnering with suppliers. The above factors support the overall branded generics market growth during the forecast period.
The Pan-Canadian Pharmaceutical Alliance, Canadian Generic Pharmaceutical Association, Centers for Disease Control and Prevention, US Food and Drug Administration, International Finance Corporation, and Indian Brand Equity Foundation are among the primary and secondary sources referred to while preparing the report on the global branded generics market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Branded Generics Market - By Therapeutic Application
1.3.2 Global Branded Generics Market - By Distribution Channel
1.3.3 Global Branded Generics Market - By Drug Class
1.3.4 Global Branded Generics Market - By Formulation Type
1.3.5 Global Branded Generics Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Branded Generics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Branded Generics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Penetration of Branded Generics
5.1.2 Increasing Government Initiatives for Promoting Branded Generics
5.2 Market Restraints
5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications
5.3 Market Opportunities
5.3.1 Product Differentiation
5.4 Future Trends
5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals
5.5 Impact Analysis
6. Branded Generics Market- Global Analysis
6.1 Global Branded Generics Market Revenue Forecast and Analysis
6.2 Global Branded Generics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Branded Generics Market - Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1.1 Teva Pharmaceuticals Industries Ltd.
6.7.1.2 Sandoz International GmbH
6.8 Market Share Analysis of Branded Generics Market
7. Global Branded Generics Market Revenue and Forecast To 2028- by Therapeutic Application
7.1 Overview
7.2 By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
7.6 Neurology
7.6.1 Overview
7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)
7.7 Gastrointestinal Diseases
7.7.1 Overview
7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.8 Dermatology Diseases
7.8.1 Overview
7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.9 Analgesics and Anti-Inflammatory
7.9.1 Overview
7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
7.10 Others
7.10.1 Overview
7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
8. Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel
8.1 Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
8.2 Hospital Pharmacies
8.2.1 Overview
8.2.2 Hospital Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.3 Retail Pharmacies
8.3.1 Overview
8.3.2 Retail Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.4 Online Pharmacies
8.4.1 Overview
8.4.2 Online Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.5 Drug Stores
8.5.1 Overview
8.5.2 Drug Stores: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9. Branded Generics Market Analysis and Forecast to 2028 by Drug Class
9.1 Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
9.2 Alkylating Agents
9.2.1 Overview
9.2.2 Alkylating Agents: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.3 Antimetabolites
9.3.1 Overview
9.3.2 Antimetabolites: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.4 Hormones
9.4.1 Overview
9.4.2 Hormones: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.5 Anti-hypertensive
9.5.1 Overview
9.5.2 Anti-hypertensive: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.6 Lipid Lowering Drugs
9.6.1 Overview
9.6.2 Lipid Lowering Drugs: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.7 Anti-Depressants
9.7.1 Overview
9.7.2 Anti-Depressants: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.8 Anti-psychotics
9.8.1 Overview
9.8.2 Anti-psychotics: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.9 Anti-epileptic
9.9.1 Overview
9.9.2 Anti-epileptic: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.10 Others
9.10.1 Overview
9.10.2 Others: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
10. Global Branded Generics Market Analysis and Forecast to 2028 - by Formulation Type
10.1 Overview
10.2 Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
10.3 Oral
10.3.1 Overview
10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)
10.4 Parenteral
10.4.1 Overview
10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
10.5 Topical
10.5.1 Overview
10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
11. Branded Generics Market Revenue and Forecasts to 2028 Geographical Analysis
11.1 North America: Branded Generics Market
11.1.1 Overview
11.1.2 North America: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.3 North America: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.4 North America: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.5 North America: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.6 North America: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.1.7 North America: Branded Generics Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.1.1 Overview
11.1.7.1.2 US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.1.3 US: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.7.1.4 US: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.7.1.5 US: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.7.1.6 US: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.1.7.2 Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.2.3 Canada: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.7.2.4 Canada: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.7.2.5 Canada: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.7.2.6 Canada: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.1.7.3 Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.7.3.3 Mexico: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.7.3.4 Mexico: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.7.3.5 Mexico: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.7.3.6 Mexico: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.2 Europe: Branded Generics Market
11.2.1 Overview
11.2.2 Europe: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.3 Europe: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.4 Europe: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.5 Europe: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.6 Europe: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)
11.2.7.1 Germany: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.1 Germany: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.2 Germany: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.3 Germany: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.4 Germany: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.1.5 Germany: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2 France: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.1 France: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.2 France: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.3 France: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.4 France: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.2.5 France: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3 UK: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.1 UK: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.2 UK: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.3 UK: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.4 UK: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.3.5 UK: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4 Italy: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.1 Italy: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.2 Italy: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.3 Italy: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.4 Italy: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.4.5 Italy: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5 Spain: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.1 Spain: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.2 Spain: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.3 Spain: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.4 Spain: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.5.5 Spain: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6 Rest of Europe: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.1 Rest of Europe: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.4 Rest of Europe: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.2.7.6.5 Rest of Europe: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
11.3 Asia Pacific Branded Generics Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.3 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.4 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.5 Asia Pacific: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.6 Asia Pacific: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.1.3 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.1.4 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.1.5 Japan: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.1.6 Japan: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.2.1 Overview
11.3.7.2.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.2.3 China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.2.4 China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.2.5 China: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.2.6 China: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7.3 India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.3.1 Overview
11.3.7.3.2 India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.3.3 India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.3.4 India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.3.5 India: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.3.6 India: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.4.3 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.4.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.4.5 South Korea: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.4.6 South Korea: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7.5 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.3.7.5.3 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.5.4 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.5.5 Australia: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.5.6 Australia: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6 Rest of Asia Pacific: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.3 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.3.7.6.4 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.3.7.6.5 Rest of Asia Pacific: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.3.7.6.6 Rest of Asia Pacific: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.4 Middle East & Africa: Branded Generics Market Revenue and Forecast To 2028
11.4.1 Overview
11.4.2 Middle East & Africa: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.4.3 Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.4.4 Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.4.5 Middle East & Africa: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.4.6 Middle East & Africa: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.4.7 Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)
11.4.7.1 UAE: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.1.1 Overview
11.4.7.1.2 UAE: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.4.7.1.3 UAE: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.4.7.1.4 UAE: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.4.7.1.5 UAE: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.4.7.1.6 UAE: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.4.7.2 Saudi Arabia: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.4.7.2.3 Saudi Arabia: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.4.7.2.4 Saudi Arabia: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.4.7.2.5 Saudi Arabia: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.4.7.2.6 Saudi Arabia: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.4.7.3 South Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.3.1 Overview
11.4.7.3.2 South Africa: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.4.7.3.3 South Africa: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.4.7.3.4 South Africa: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.4.7.3.5 South Africa: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.4.7.3.6 South Africa: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.4.7.4 Rest of Middle the East and Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.4.7.4.3 Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.4.7.4.4 Rest of Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.4.7.4.5 Rest of Middle East & Africa: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.4.7.4.6 Rest of Middle East & Africa: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.5 South and Central America Branded Generics Market Revenue and Forecast to 2028
11.5.1 Overview
11.5.2 South & Central America Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.3 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.4 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.5 South & Central America: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.5.6 South & Central America: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.5.7 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
11.5.7.1 Argentina Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.5.7.1.1 Overview
11.5.7.1.2 Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.1.3 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.1.4 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.1.5 Argentina: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.5.7.1.6 Argentina: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2 Brazil: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2.1 Overview
11.5.7.2.2 Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.2.3 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.2.4 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.2.5 Brazil: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.5.7.2.6 Brazil: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
11.5.7.3 Rest of South and Central America: Branded Generics Market- Revenue and Forecast to 2028 (USD Billion)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.5.7.3.3 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.5.7.3.4 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.5.7.3.5 Rest of South & Central America: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
11.5.7.3.6 Rest of South & Central America: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
12. Impact Of COVID-19 Pandemic on Branded Generics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 SAM: Impact Assessment of COVID-19 Pandemic
13. Branded Generics Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 MYLAN N.V.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bausch Health Companies Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Lupin
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ASTRAZENECA PLC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Dr. Reddy's Laboratories
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Par Pharmaceuticals, INC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sandoz International GMBH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Aspen Holdings
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Hetero
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 2. North America Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 3. North America Branded Generics Market, by Drug Class- Revenue and Forecast to 2028 (US$ Billion)
Table 4. North America Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 5. US Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 6. US Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 7. US Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 8. US Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 9. Canada: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 10. Canada Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 11. Canada Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 12. Canada Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 13. Mexico: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 14. Mexico Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 15. Mexico Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 16. Mexico Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 17. Europe: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 18. Europe: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 19. Europe: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 20. Europe: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 21. Germany: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 22. Germany: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 23. Germany: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 24. Germany: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 25. France: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 26. France: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 27. France: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 28. France: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 29. UK: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 30. UK: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 31. UK: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 32. UK: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 33. Italy: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 34. Italy: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 35. Italy: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 36. Italy: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 37. Spain: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 38. Spain: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 39. Spain: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 40. Spain: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 41. Rest of Europe: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 42. Rest of Europe: Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 43. Rest of Europe: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 44. Rest of Europe: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 45. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).
Table 46. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 47. Asia Pacific: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 48. Asia Pacific: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 49. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 50. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 51. Japan: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 52. Japan: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 53. China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 54. China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 55. China: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 56. China: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 57. India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 58. India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 59. India: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 60. India: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 61. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 62. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 63. South Korea: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 64. South Korea: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 65. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 66. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 67. Australia: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 68. Australia: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 69. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 70. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 71. Rest of Asia Pacific: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 72. Rest of Asia Pacific: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 73. Middle East & Africa Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 74. Middle East & Africa Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (USD Billion)
Table 75. Middle East & Africa Branded Generics Market, by Drug Class- Revenue and Forecast to 2028 (US$ Billion)
Table 76. Middle East & Africa Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 77. UAE Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 78. UAE Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 79. UAE Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 80. UAE Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 81. Saudi Arabia: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 82. Saudi Arabia Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 83. Saudi Arabia Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 84. Saudi Arabia Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 85. South Africa: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 86. South Africa Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 87. South Africa Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 88. South Africa Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 89. Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 90. Rest of Middle East & Africa Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 91. Rest of Middle East & Africa Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 92. Rest of Middle East & Africa Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 93. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).
Table 94. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 95. South & Central America: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 96. South & Central America: Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 97. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 98. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 99. Argentina: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 100. Argentina: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 101. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 102. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 103. Brazil: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 104. Brazil: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 105. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 106. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 107. Rest of South & Central America: Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 108. Rest of South & Central America: Branded Generics Market, by Formulation Type- Revenue and Forecast to 2028 (US$ Billion)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms
LIST OF FIGURES
Figure 1. Branded Generics Market Segmentation
Figure 2. Branded Generics Market, By Region
Figure 3. Global Branded Generics Market Overview
Figure 4. Others Segment Held Largest Share of Drug Class Segment in Branded Generics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Branded Generics Market, by Geography (US$ Million)
Figure 7. Global Branded Generics Market - Leading Country Markets (US$ Billion)
Figure 8. Global Branded Generics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints on Branded Generics Market
Figure 16. Global Branded Generics Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 17. Global Branded Generics Market - By Geography Forecast and Analysis - 2022 - 2028
Figure 18. Market Positioning of Key Players in Branded Generics Market
Figure 19. Global Branded Generics Market - Market Potential Analysis, By Region
Figure 20. Global Branded Generics Market - Comparative Company Analysis
Figure 21. Global Branded Generics Market - Growth Strategy Analysis
Figure 22. Market Share Analysis of Key Players in Global Branded Generics Market
Figure 23. By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)
Figure 24. Oncology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 25. Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 26. Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
Figure 27. Neurology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 28. Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 29. Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 30. Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
Figure 31. Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 32. Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 33. Hospital Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 34. Retail Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 35. Online Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 36. Drug Stores: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 37. Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
Figure 38. Alkylating Agents: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 39. Antimetabolites: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 40. Hormones: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 41. Anti-hypertensive: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 42. Lipid Lowering Drugs: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 43. Anti-Depressants: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 44. Anti-psychotics: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 45. Anti-epileptic: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 46. Others: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 47. Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
Figure 48. Oral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 49. Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 50. Topical Market Revenue and Forecast to 2028 (US$ Billion)
Figure 51. Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 52. North America: Branded Generics Market, by Key Country - Revenue (2022) (US$ Billion)
Figure 53. North America Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 54. North America: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 55. US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 56. Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 57. Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 58. Europe: Branded Generics Market, by Key Country - Revenue (2022) (US$ Billion)
Figure 59. Europe: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 60. Europe: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 61. Germany: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 62. France: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 63. UK: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 64. Italy: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 65. Spain: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 66. Rest of Europe: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 67. Asia Pacific Branded Generics Market Overview, by Country (2022)
Figure 68. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 69. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
Figure 70. Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 71. China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 72. India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 73. South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 74. Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 75. Rest of Asia Pacific: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 76. Middle East & Africa: Branded Generics Market, by Key Country - Revenue (2022) (US$ Billion)
Figure 77. Middle East & Africa Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
Figure 78. Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 79. UAE: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 80. SAudi Arabia: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 81. South Africa: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 82. Rest of Middle East & Africa: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 83. South & Central America Branded Generics Market Overview, by Country (2022)
Figure 84. South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 85. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
Figure 86. Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 87. Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 88. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
Figure 89. Impact of COVID-19 Pandemic in North American Country Markets
Figure 90. Impact of COVID-19 Pandemic in European Country Markets
Figure 91. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 92. Impact of COVID-19 Pandemic in Middle East & African Country Markets
Figure 93. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 94. Growth Strategies Done by the Companies in the Market (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security